Rosacea Channel
Topics & Medications
Quicklinks
Related Channels

Generic Mirvaso

No generic forms of Mirvaso (brimonidine gel) are available at this time. A generic version is not expected to become available until after the first patent expires, which is not until May 2025. Although brimonidine is sometimes called the "generic name" for Mirvaso, it is simply the active ingredient in the product.

 

Can I Buy Generic Mirvaso?

Mirvaso® (brimonidine gel) is a prescription skin medication approved for the treatment of rosacea. It is applied to the skin once daily and helps to immediately and temporarily treat redness.
 
Mirvaso gel is made by Galderma Laboratories. It is currently under the protection of a patent that prevents any generic versions from being manufactured in the United States.  
 

When Will a Generic Version Be Available?

The first patent for Mirvaso is set to expire in May 2025. This is the earliest predictable date that a generic version could become available.
 
However, other circumstances could come up to delay or shorten this exclusivity period. This could include things such as lawsuits or other patents for new Mirvaso uses. Once the patent expires, several companies may start manufacturing a generic Mirvaso drug.
 

Is Brimonidine a Generic Mirvaso?

No -- brimonidine is the active ingredient in Mirvaso, not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
 
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
 

Mirvaso Gel Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.